The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...

Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...

US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...

(Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today ...

Analysts are intrested in these 5 stocks: ( ($VZLA) ), ( ($COTY) ), ( ($KLRS) ), ( ($ANNX) ) and ( ($BRO) ). Here is a breakdown of their recent ...

Electricity has always been central to how life works, from the firing of neurons to the beating of the heart, but new ...

For South Carolina residents, Miracle Hill isn’t just a store – it’s a community institution, a budget-stretcher, and a ...

Oregon Ridge Park in Cockeysville is the escape hatch you never knew you needed – a sprawling natural sanctuary just a short drive from Baltimore’s urban hustle. Have you ever discovered something so ...

From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...

There are "costs of life" that mechanical physics cannot calculate. A clear example is the energy required to keep specific ...

Pegcetacoplan significantly reduces proteinuria in patients with recurrent C3 glomerulopathy, or primary immune-complex ...